Impact of tobacco smoking on thyroid ultrasound image assessed among random population of spa patients in Kołobrzeg, Poland
Languages of publication
Tobacco smoking increases the risk of many diseases, but its association with thyroid disorders remains unclear. Most studies show higher incidence of thyroid nodularity in the populations of smokers. Due to its pro-inflammatory effect, tobacco is said to play an important role also in the development of thyroid inflammation. However, our study showed opposite results. We performed a research on a population of 75 spa guests in Poland. The study was based on surveys and ultrasound thyroid examination. Among examined patients, thyroid nodularity was more common in non-smokers than in smokers. Focal changes were detected in 25,00% of smokers and in 48,00% of non-smokers. Examined smokers presented also less abnormalities in the thyroid echogenicity. Heterogenous thyroid echogenicity was detected in 40,00% of smokers and in 52% of non-smokers. 49,21% of the examined population had enlarged thyroid gland. Among the group with enlarged thyroid gland only 24,30% were smokers and 75,70% were non-smokers. Such results can be explained by a small study group of patients. Another aspect is the type of the group- it turned out, that most of the patients who were interested in participation in the study, presented thyroid diseases in the past.
- Department of Internal Medicine, Pleszewskie Medical Centre, 125a Poznańska Str., 63-300 Pleszew, Poland
- Chair and Department of Gastroenterology, Nutrition and Internal Medicine, Poznan University of Medical Sciences, 49 Przybyszewskiego Str., 60-355 Poznań, Poland
- Chair and Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 49 Przybyszewskiego Str., 60-355 Poznań, Poland
-  Balhara YP, Deb KS. Impact of tobacco on thyroid function. Thyr Res Pract. 2014; 11(1): 6-13.
-  Fowles J, Dybing E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob Control 2003; 12: 424-30.
-  Fukuyama H, Nasu M, Murakami S, Sugawara M. Examination of antythyroid effects of smoking products in cultured thyroid follicles: only thiocyanate is a potent antythyroid agent. Acta Endocrinol 1992; 127: 520-5.
-  Tziomalos K, Charsoulis F. Endocrine effects of tobaccosmoking. Clin Endocrinol 2004; 61: 664-74.
-  Utiger RD. Effects of smoking on thyroid function. Eur J Endocrinol 1998; 138:368-9.
-  Matta SG, Fu Y, Valentine JD, Sharp BM. Response of the hypothalamo-pituary-adrenal axis to nicotine. Psychoneuro endocrinology 1998; 22: 287-92.
-  Bartalena L, Bogazzi F, Tanda ML et al. Cigarette smoking and the thyroid. Eur J Endocrinol 1995; 133: 507-12.
-  Ferrari SM, Fallahi P, Antonelli A et al. Environmental Issues in Thyroid Diseases. Front Endocrinol 2017; 8(50): 1-8.
-  Vestergaard P. Smoking and thyroid disorders- a meta- analysis. Eur J Endocrinol 2002; 146: 153-61.
-  Hegedius L, Brix TH, Vestergaad P. Relationship between cigarette smoking and Graves’ opthalmopathy. J Endocrinol Invest 2004; 27: 265-71.
-  Lio S, Napolitano G, Marinuzzi G et al. Role of smoking in goiter morphology and thyrotropin response to TRH in untreated goitrous women. J Endocrinol Invest 1989; 12: 93-7.
-  Aydin LY, Besir FH, Demirin H et al. Effect of smoking intensity on thyroid volume, thyroid nodularity and thyroid function: The Melen study. Minerva Endocrinol 2011; 36: 273-80.
-  Knudsen N, Bulow I, Laurberg P et al. Assocation of tobacco smoking with goiter in a low-iodine-intake area. Arch Intern Med 2002; 162: 439-43.
-  Ittermann T, Schmidt CO, Kramer A et al. Smoking as a risk factor for thyroid volume progresson and incident goiter in a region of improved iodine supply. Eur J Endocrinol 2008; 159: 761-6.
-  Knudsen N, Bulow I, Laurberg P et al. High occurrence of thyroid multinodularity and low occurrence of subclinical hypothyroidism among tobacco smokers in a large population study. J Endocrinol 2002; 175: 571-576.
Publication order reference